GlaxoSmithKline (GSK) Signs Potential $1 Billion Drug Deal with Chroma Therapeutics
6/23/2009 8:05:38 AM
More...
|
Invitrogen Corporation (IVGN) and Chroma Therapeutics Extend Kinase Screening Partnership
2/25/2008 8:47:43 AM
More...
|
Chroma Therapeutics Announces Positive Phase I Efficacy Data for Novel Cancer Therapy CHR-2797
12/13/2007 8:42:52 AM
More...
|
Chroma Therapeutics to Present Phase I Efficacy Data for Novel Cancer Therapy CHR-2797
11/30/2007 7:01:11 AM
More...
|
Chroma Therapeutics Progresses Novel Cancer Therapy CHR-2797 Into Phase II Solid Tumour Study; Presents Phase I Data at American Society of Clinical Oncology
6/13/2007 10:19:00 AM
More...
|
Chroma Therapeutics Progresses Novel Cancer Therapy Into Phase II Clinical Development
3/26/2007 10:53:56 AM
More...
|
Discovery Partners International (Headquarter) (DPII) And Chroma Therapeutics Entered Into A Collaboration For Lead Identification On Multiple Targets
10/19/2005 5:13:09 PM
More...
|
Chroma Therapeutics Raises $18.1M In Series B Financing
10/19/2005 5:08:45 PM
More...
|